Recombinant Human FAM217A Protein ，His

FAM217A, a member of the FAM217 family of proteins, has garnered attention in recent years due to its potential roles in cellular processes and implications for various diseases. This protein is involved in crucial biological functions, including cell proliferation, differentiation, and apoptosis, making it a subject of interest in cancer research. Recent studies have suggested that FAM217A may act as an important regulator of oncogenic pathways, influencing tumor progression and metastasis. Additionally, gene expression analyses have indicated that FAM217A is differentially expressed in several cancer types, which raises the possibility of its use as a biomarker for diagnosis or prognosis. The recombinant expression of FAM217A facilitates in-depth functional analysis through the production of large quantities of the protein, enabling researchers to investigate its biochemical properties, interaction with other proteins, and influence on cellular signaling pathways. Understanding the precise mechanisms by which FAM217A contributes to disease may provide new avenues for therapeutic interventions. Furthermore, the study of FAM217A in the context of autoimmune diseases and other cellular dysfunctions is emerging, suggesting its broader relevance in human health. Overall, ongoing research into FAM217A and its recombinant protein applications promises to shed light on its biological significance and potential therapeutic roles across a range of pathological conditions.